Equine encephalitis viruses

The equine encephalitis viruses are three related New World alphaviruses, Eastern, Western and Venezuelan equine encephalitis virus, that cause encephalitis in horses and in people across the Americas. All three are mosquito-borne and maintained in animal reservoirs, with humans and horses usually incidental hosts, and all three can invade the brain, but they differ sharply in how dangerous they are. Eastern equine encephalitis is the most feared, a rare but frequently fatal encephalitis; Western equine encephalitis is milder and has become vanishingly rare; and Venezuelan equine encephalitis is usually a self-limited febrile illness that only occasionally reaches the brain, but which can explode into large epidemics amplified by horses. None occurs naturally in South Africa, where their significance is as an imported differential in a returning traveller. There is no specific antiviral for any of them and no licensed human vaccine, so care is supportive and prevention rests on the mosquito.

Discovery and historical significance

The three viruses were isolated from encephalitic horses within a few years of one another in the 1930s. Western equine encephalitis virus was recovered in 1930 from the brains of affected horses in the San Joaquin Valley of California, the first alphavirus ever grown in culture, and the plaque assay was later developed using this virus on chick embryo cells. Eastern equine encephalitis virus followed in 1933, isolated from horse brains during outbreaks on the eastern seaboard of the United States, and Venezuelan equine encephalitis virus in 1936 from horses in the Guajira region of Venezuela. Human disease was confirmed for each over the following years, often first in laboratory workers or in children during equine outbreaks.

The viruses have a further significance in the history of biological weapons: their high infectivity by the aerosol route, demonstrated by numerous laboratory-acquired infections, led Venezuelan equine encephalitis virus in particular to be studied and stockpiled as a potential agent, and it remains a recognised biothreat.

Classification, structure, and genome

Classification

The three viruses are the species Alphavirus eastern, Alphavirus western and Alphavirus venezuelan in the genus Alphavirus, family Togaviridae, and each is the type member of its own antigenic complex. Together they are the principal New World encephalitic alphaviruses, distinct from the Old World arthritogenic group. Several related viruses sit within these complexes. Within the Eastern complex, the strains formerly regarded as South American Eastern equine encephalitis virus have been reclassified as a separate species, Madariaga virus, which is generally much less virulent in people than North American Eastern equine encephalitis virus. The Venezuelan complex contains several enzootic relatives (including Everglades, Mucambo and Tonate viruses), and the epidemic-causing strains fall within subtypes of Venezuelan equine encephalitis virus itself. Western equine encephalitis virus is a natural recombinant, its genome descended from an Eastern-equine-encephalitis-like ancestor with the structural genes of a Sindbis-like virus.

New World encephalitic alphaviruses at a glance

Virus	Distribution	Reservoir	Main enzootic vector	Incubation	Human case-fatality
Eastern (EEEV)	Eastern North America, Caribbean	Passerine birds	Culiseta melanura	~4 to 10 days	~30 to 75%
Western (WEEV)	Western North and South America	Passerine birds	Culex tarsalis	~5 to 10 days	~3%
Venezuelan (VEEV)	Central and South America	Forest rodents	Culex (Melanoconion)	~2 to 5 days	~1%

Virion structure

Each is a typical alphavirus particle: enveloped, roughly spherical, about 70 nm across, with a single capsid protein forming an icosahedral nucleocapsid on a triangulation number of 4. The host-derived envelope carries 80 glycoprotein spikes, each a trimer of paired E1 and E2 heterodimers, in which E2 mediates receptor attachment and E1 carries the fusion machinery.

Genome organisation

The genome is a single molecule of positive-sense RNA of about 11.7 kilobases, capped and polyadenylated. Its 5’ two-thirds encodes the four nonstructural proteins as a polyprotein, and the structural proteins are translated from a subgenomic messenger RNA. nsP4 is the RNA-dependent RNA polymerase, and the remaining nonstructural proteins provide the capping, protease, helicase and host-range functions common to the genus.

Replication cycle

The three viruses follow the general alphavirus cycle. Attachment is mediated by E2 to cell-surface receptors; for Venezuelan equine encephalitis virus the low-density lipoprotein receptor-related protein LDLRAD3 is a key entry receptor, while the others use their own combinations of receptors and attachment factors. The particle enters by clathrin-mediated endocytosis, and the acid endosome triggers E1 to fold into a fusion trimer that merges the membranes and delivers the nucleocapsid to the cytoplasm.

The incoming genome is translated into the nonstructural polyprotein, which assembles the replication complex and copies a minus-strand template; from this the virus makes abundant new genomes and the subgenomic RNA for the structural proteins. Capsid protein packages new genomes into nucleocapsids, the glycoproteins mature through the secretory pathway, and progeny bud through the plasma membrane.

Pathogenesis

All three viruses are neurotropic, and the central event in severe disease is invasion of the brain. After a mosquito deposits virus in the skin, it replicates first in peripheral tissues, in muscle and fibroblasts for the encephalitic viruses generally and in Langerhans cells for Venezuelan virus, and drains to lymph nodes, from which a viraemia seeds the target organs. Neuroinvasion can occur across the cerebral vasculature, through the choroid plexus, or along the olfactory route, and once in the brain the virus infects neurons, whose death and the accompanying inflammation produce the encephalitis.

Susceptibility to fatal neurological disease is strongly age-dependent, falling most heavily on young children and older adults, a pattern that reflects in part the way immature neurons are more readily killed by these viruses. Eastern equine encephalitis virus is the most neurovirulent, producing widespread neuronal destruction with prominent involvement of the basal ganglia, thalamus and brainstem. Venezuelan equine encephalitis virus has an additional tropism for lymphoid tissue, which contributes to its more systemic, febrile presentation, with encephalitis in only a minority.

Epidemiology

Each virus is maintained in its own enzootic cycle, and the ecology explains the distribution of human disease. Eastern equine encephalitis virus circulates between passerine birds and the mosquito Culiseta melanura in freshwater hardwood swamps of eastern North America, with other, less host-specific mosquitoes acting as bridge vectors to horses and people; human cases are few, historically only a handful a year in the United States, but the northeastern states have seen larger clusters in recent years and a northward expansion of activity. Western equine encephalitis virus cycled between birds and Culex tarsalis across the western plains and river valleys, but human disease has all but disappeared, with no North American case for many years for reasons that appear ecological rather than a loss of virulence.

Venezuelan equine encephalitis virus is different. It has two cycles: an enzootic cycle in forest rodents with Culex (Melanoconion) mosquitoes, causing sporadic mild human illness, and an epizootic cycle in which mutation of an enzootic strain produces a variant that replicates to high titre in horses. The horse then acts as an amplifying host, and floodwater mosquitoes carry the virus onward, driving explosive epidemics across Central and South America that can involve tens or hundreds of thousands of people, as in the outbreak that reached Texas in 1971 and the Venezuela and Colombia epidemic of 1995.

Natural history

After an incubation of about two to ten days, depending on the virus, illness begins with fever, headache and malaise. In the encephalitic course, this febrile prodrome gives way over a few days to signs of brain involvement, with headache, vomiting, altered consciousness and seizures.

The subsequent course varies enormously by virus. Eastern equine encephalitis progresses rapidly and often to death within days, and survivors are frequently left with serious neurological damage. Western equine encephalitis usually resolves, though infants may be left with lasting harm. Venezuelan equine encephalitis is, in most people, a self-limited febrile illness lasting a few days from which recovery is complete, with only a small minority progressing to encephalitis. Recovery from any of them confers lasting immunity to that virus.

Clinical presentations and complications

Eastern equine encephalitis

Eastern equine encephalitis is the most severe arboviral encephalitis in the Americas. A prodrome of fever, headache and myalgia is followed by rapidly progressive encephalitis with vomiting, seizures, focal signs and coma. The case-fatality is of the order of 30% or higher, and a large proportion of survivors, especially children, are left with significant long-term neurological deficits. Hyponatraemia from inappropriate antidiuretic hormone secretion is common, and magnetic resonance imaging characteristically shows lesions in the basal ganglia, thalamus and brainstem.

Western equine encephalitis

Western equine encephalitis is generally milder. After a febrile prodrome, most adults develop a self-limited illness or a moderate encephalitis from which they recover, and the overall case-fatality is low. The exception is the infant, in whom the disease can be severe, with seizures and a substantial risk of permanent brain damage in survivors.

Venezuelan equine encephalitis

Venezuelan equine encephalitis is predominantly a systemic febrile illness rather than an encephalitis. Most infected people develop an abrupt influenza-like illness with fever, headache, myalgia and prostration lasting a few days. Frank encephalitis occurs in only a small proportion, mainly children, in whom it can be fatal, and the systemic illness in pregnancy can harm the fetus. During epizootics, horses develop a severe and often fatal illness in parallel.

Diagnosis

Diagnosis rests on serology, with virus-specific IgM in serum and cerebrospinal fluid and a rising or seroconverting IgG titre on paired sera. Because the viraemia is brief and often past by the time encephalitis appears, antibody testing is usually more useful than direct detection for the encephalitic viruses, though reverse-transcription PCR can detect virus early, particularly in the febrile phase of Venezuelan infection, and virus can be isolated in cell culture or newborn mice. Cerebrospinal fluid shows a raised white cell count, initially with neutrophils, and imaging supports the diagnosis in Eastern disease. Cross-reactivity within the genus means confirmation may need neutralisation testing at a reference laboratory.

Management

There is no specific antiviral for any of the equine encephalitis viruses, and management is supportive. Severe encephalitis requires intensive care, with control of seizures, management of raised intracranial pressure, correction of the hyponatraemia of inappropriate antidiuretic hormone secretion, and general organ support. Outcome is determined by the virus and the host rather than by any specific therapy, and the emphasis for the clinician is early recognition, exclusion of treatable alternatives such as herpes simplex encephalitis, and supportive management.

Prevention and public health

Vector control

Prevention depends on reducing contact between people, horses and the vector mosquitoes. Personal protection with repellents and clothing, avoidance of exposure at times of peak mosquito activity, and community mosquito control through larviciding and, during outbreaks, adulticiding are the mainstays, guided by surveillance of mosquitoes and sentinel birds or horses that signals rising activity before human cases appear.

Vaccination

There is no licensed human vaccine against any of the equine encephalitis viruses. Formalin-inactivated veterinary vaccines protect horses and are central to controlling epizootics, especially of Venezuelan virus, and investigational human vaccines exist for laboratory workers at occupational risk, including a live-attenuated Venezuelan vaccine strain and inactivated preparations, all with limitations that have kept them from general use.

Infection prevention and control

Venezuelan equine encephalitis virus is highly infectious by the aerosol route and has caused many laboratory-acquired infections, so it is handled under enhanced biosafety containment, and it is classed as a potential biothreat agent. The bird-associated Eastern and Western viruses pose less of a laboratory-aerosol hazard but are still handled with appropriate containment.

Surveillance and notification

The arboviral encephalitides are notifiable in the countries where they occur and are tracked through arboviral surveillance systems that integrate human cases with mosquito and animal data. During a Venezuelan equine encephalitis epizootic, control combines equine vaccination, restriction of horse movement, and intensified vector control.

South African context

None of the equine encephalitis viruses is endemic in South Africa; they are New World agents, and their relevance to South African practice is as an imported differential diagnosis in a traveller returning from the Americas with a febrile or encephalitic illness. The locally important alphaviruses of southern Africa are instead Sindbis virus, which causes a febrile arthritis, and the related Middelburg and Ndumu viruses, which are recognised occasionally in animals and, rarely, in people. Suspected arboviral disease in a returning traveller is investigated with the support of the National Institute for Communicable Diseases arbovirus programme, which provides the specialised serological and molecular testing needed to distinguish these agents.

References and recommended reading

• Griffin DE, Weaver SC. Alphaviruses. In: Fields Virology, 7th edition. Philadelphia: Wolters Kluwer; 2023. The principal reference for the classification, virion structure, genome, replication cycle, pathogenesis and epidemiology set out here.
• Smith DW, Mackenzie JS, Frolov IV, Weaver SC. Alphaviruses. In: Richman DD, Whitley RJ, Hayden FG (eds.), Clinical Virology, 4th edition. Washington: ASM Press; 2016. The source for the clinical spectrum, case-fatality and diagnostic approach of the three viruses.
• Burrell CJ, Howard CR, Murphy FA. Togaviruses. In: Fenner and White’s Medical Virology, 5th edition. London: Academic Press / Elsevier; 2017. A concise account of the equine encephalitis viruses and their transmission cycles.
• National Institute for Communicable Diseases. Arboviral Disease (disease index and guidance). Johannesburg: NICD; 2025. The source for the South African arbovirus surveillance and clinical context.